Skip to content

Efficacy of Periorbital Rejuvenation With a 1927 nm Diode Laser Treatment

An Open-Label, Single Center Clinical Study to Evaluate the Efficacy of Periorbital Rejuvenation With a 1927 nm Diode Laser Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05811026
Enrollment
20
Registered
2023-04-13
Start date
2023-03-15
Completion date
2024-12-31
Last updated
2025-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laser, Periorbital

Keywords

1927 nm, periorbital rejuvenation

Brief summary

The purpose of this research project is to investigate the treatment design, therapeutic effects and safety of the 1927 nm laser for the rejuvenation of the skin around the eyes.

Detailed description

The chromophore of the 1927 nm diode laser is mainly water, which can be used for skin rejuvenation. This study intends to use the Solta CLEAR+BRILLIANT Laser System, featuring a 1927 nm diode laser with 5 mJ energy, a treatment spot of 140 μm, a treatment depth of 170 μm, and a treatment coverage of approximately 5% per energy level after four rounds of treatment using the patented Intelligent Optical Tracking® System (IOTs). The purpose of this research project is to investigate the treatment design, therapeutic effects and safety of the 1927 nm laser for the rejuvenation of the skin around the eyes. This is an open-label, single-center clinical trial. Participants will be randomized into treatment groups, including Group A (treatment interval of 2 weeks) or Group B (treatment interval of 4 weeks).

Interventions

DEVICEPeriorbital rejuvenation with a 1927 nm diode laser treatment (2-week interval)

* Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment * Visit 2 (W2): Clear + Brilliant™ Permea device periorbital treatment * Visit 3 (W4): Clear + Brilliant™ Permea device periorbital treatment * Visit 4 (W8): Four weeks after the third treatment, a follow-up assessment will be performed

DEVICEPeriorbital rejuvenation with a 1927 nm diode laser treatment (4-week interval)

* Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment * Visit 2 (W4): Clear + Brilliant™ Permea device periorbital treatment * Visit 3 (W8): Clear + Brilliant™ Permea device periorbital treatment * Visit 4 (W12): Four weeks after the third treatment, a follow-up assessment will be performed

Sponsors

BRIDGECON CO,.LTD.
CollaboratorUNKNOWN
National Taiwan University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

1. aged between 30 and 65 years old; 2. no significant skin lesions or inflammation on the facial skin; 3. willing and able to comply with study requirements, instructions, and restrictions; 4. signed informed consent form.

Exclusion criteria

1. underwent facial active treatment, such as using laser, intense pulsed light, radiofrequency skin tightening, ultrasound skin tightening, botulinum toxin, or dermal fillers injection, within the previous six months; 2. have chronic skin diseases such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo, rosacea, or keloid; 3. pregnant or breastfeeding; 4. suffered from acute illnesses or infections requiring treatment within 14 days before entering the study; 5. have had serious illnesses (such as heart disease, lung disease, brain disease, or liver disease) within the previous three months; 6. allergic to Lidocaine or Prilocaine used in topical anesthetic cream or suffer from methemoglobinemia; 7. used any skin medication on the face within 30 days before the trial, deemed by the principal investigator to affect the study results; 8. deemed unsuitable for the study by the principal investigator.

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Texture Score at Visit 4 (End-of-study Session)Group A: baseline and week 8; Group B: baseline and week 12The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 4 = texture score at Visit 4 - texture score at baseline

Secondary

MeasureTime frameDescription
Change From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)Group A: baseline and week 8; Group B: baseline and week 12The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 4 = pigmentation score at Visit 4 - pigmentation score at baseline
Change From Baseline in Pores' Index at Visit 4 (End-of-study Session)Group A: baseline and week 8; Group B: baseline and week 12The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 4 = pores' index at Visit 4-pores' indexe at baseline
Change From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)Group A: baseline and week 8; Group B: baseline and week 12The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 4 = wrinkles' score at Visit 4 - wrinkles' score at baseline
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)Group A: baseline and week 8; Group B: baseline and week 12Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)Group A: baseline and week 8; Group B: baseline and week 12Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.
Change From Baseline in Texture Score at Visit 2Group A: baseline and week 2; Group B: baseline and week 4The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 2 = texture score at Visit 2 - texture score at baseline
Change From Baseline in Color Measurements (L*) at Visit 2Group A: baseline and week 2; Group B: baseline and week 4In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 2 = L\* at Visit 2 - L\* at baseline
Change From Baseline in Pigmentation Score at Visit 2Group A: baseline and week 2; Group B: baseline and week 4The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 2 = pigmentation score at Visit 2 - pigmentation score at baseline
Change From Baseline in Pores' Index at Visit 2Group A: baseline and week 2; Group B: baseline and week 4The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 2 = pores' index at Visit 2 - pores' index at baseline
Change From Baseline in Wrinkles' Score at Visit 2Group A: baseline and week 2; Group B: baseline and week 4The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 2 = wrinkles' score at Visit 2 - wrinkles' score at baseline
Change From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)Group A: baseline and week 8; Group B: baseline and week 12In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 4 = L\* at Visit 4 - L\* at baseline
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2Group A: baseline and week 2; Group B: baseline and week 4Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.
Change From Baseline in Texture Score at Visit 3Group A: baseline and week 4; Group B: baseline and week 8The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 3 = texture score at Visit 3 - texture score at baseline
Change From Baseline in Color Measurements (L*) at Visit 3Group A: baseline and week 4; Group B: baseline and week 8In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 3 = L\* at Visit 3 - L\* at baseline
Change From Baseline in Pigmentation Score at Visit 3Group A: baseline and week 4; Group B: baseline and week 8The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 3 = pigmentation score at Visit 3 - pigmentation score at baseline
Change From Baseline in Pores' Index at Visit 3Group A: baseline and week 4; Group B: baseline and week 8The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 3 = pores' index at Visit 3 - pores' index at baseline
Change From Baseline in Wrinkles' Score at Visit 3Group A: baseline and week 4; Group B: baseline and week 8The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 3 = wrinkles' score at Visit 3 - wrinkles' score at baseline
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3Group A: baseline and week 4; Group B: baseline and week 8Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.
Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3Group A: baseline and week 4; Group B: baseline and week 8Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.
Visual Analogue Scale (VAS) During TreatmentGroup A: week 0; Group B: week 0The visual analogue scale (VAS) is a psychometric response scale that can be used in questionnaires, which a higher score suggests greater pain intensity. It ranges from 0 to 10 in increments of 1. A score of 0 cm indicates no pain and 10 indicates worst pain imaginable.
Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2Group A: baseline and week 2; Group B: baseline and week 4Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.

Countries

Taiwan

Participant flow

Participants by arm

ArmCount
Arm A: 2-week Interval Between Treatments
The interval between the first, second, and third treatments in this arm is two weeks, and the follow-up session will take place four weeks after the third treatment. Periorbital rejuvenation with a 1927 nm diode laser treatment (2-week interval): - Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment * Visit 2 (W2): Clear + Brilliant™ Permea device periorbital treatment * Visit 3 (W4): Clear + Brilliant™ Permea device periorbital treatment * Visit 4 (W8): Four weeks after the third treatment, an end-of-study assessment will be performed
10
Arm B: 4-week Interval Between Treatments
The interval between the first, second, and third treatments in this arm is four weeks, and the follow-up session will take place four weeks after the third treatment. Periorbital rejuvenation with a 1927 nm diode laser treatment (4-week interval): - Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment * Visit 2 (W4): Clear + Brilliant™ Permea device periorbital treatment * Visit 3 (W8): Clear + Brilliant™ Permea device periorbital treatment * Visit 4 (W12): Four weeks after the third treatment, an end-of-study assessment will be performed
10
Total20

Baseline characteristics

CharacteristicArm A: 2-week Interval Between TreatmentsTotalArm B: 4-week Interval Between Treatments
Age, Continuous53 years48 years45 years
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
10 Participants20 Participants10 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Taiwan
10 Participants20 Participants10 Participants
Sex: Female, Male
Female
9 Participants18 Participants9 Participants
Sex: Female, Male
Male
1 Participants2 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
1 / 103 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Change From Baseline in Texture Score at Visit 4 (End-of-study Session)

The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 4 = texture score at Visit 4 - texture score at baseline

Time frame: Group A: baseline and week 8; Group B: baseline and week 12

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Texture Score at Visit 4 (End-of-study Session)0.25 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Texture Score at Visit 4 (End-of-study Session)-4.75 score on a scale
p-value: 0.075Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Color Measurements (L*) at Visit 2

In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 2 = L\* at Visit 2 - L\* at baseline

Time frame: Group A: baseline and week 2; Group B: baseline and week 4

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Color Measurements (L*) at Visit 2-0.4711 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Color Measurements (L*) at Visit 2-0.44215 score on a scale
p-value: 0.4274Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Color Measurements (L*) at Visit 3

In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 3 = L\* at Visit 3 - L\* at baseline

Time frame: Group A: baseline and week 4; Group B: baseline and week 8

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Color Measurements (L*) at Visit 3-1.1979 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Color Measurements (L*) at Visit 3-0.26345 score on a scale
p-value: 0.0982Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)

In the CIELAB color space, the L\* value represents the lightness of a color, indicating how light or dark it appears. The scale ranges from 0 (black) to 100 (white), providing a standardized measure of brightness that aligns with human visual perception. This metric is particularly useful in assessing skin tone. The average L\* value within a region of interest was calculated at each visit. Change from baseline in L\* at Visit 4 = L\* at Visit 4 - L\* at baseline

Time frame: Group A: baseline and week 8; Group B: baseline and week 12

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)-0.61495 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Color Measurements (L*) at Visit 4 (End-of-study Session)-0.798575 score on a scale
p-value: 0.4727Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.

Time frame: Group A: baseline and week 2; Group B: baseline and week 4

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 23.0 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 23.0 score on a scale
p-value: 0.3327Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.

Time frame: Group A: baseline and week 4; Group B: baseline and week 8

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 33.0 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 32.0 score on a scale
p-value: 0.0067Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Patient Assessment of GAIS refers to the GAIS score evaluated by the patient. Change from Baseline in Patient Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.

Time frame: Group A: baseline and week 8; Group B: baseline and week 12

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)3.0 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Patient Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)2.0 score on a scale
p-value: 0.1009Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 2

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 2 is defined as the GAIS score assessed at Visit 2 in comparison to baseline.

Time frame: Group A: baseline and week 2; Group B: baseline and week 4

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 24.0 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 24.0 score on a scale
p-value: 0.6231Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 3

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 3 is defined as the GAIS score assessed at Visit 3 in comparison to baseline.

Time frame: Group A: baseline and week 4; Group B: baseline and week 8

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 33.5 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 33.7 score on a scale
p-value: 0.6961Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)

Global Aesthetic Improvement Score (GAIS) is a standardized 5-point scale used to assess overall aesthetic improvement following a cosmetic treatment. It ranges as follows: 5 - Very Much Improved, 4 - Much Improved, 3 - Improved, 2 - No Change, 1 - Worse Physician Assessment of GAIS refers to the GAIS score evaluated by the physician. Change from Baseline in Physician Assessment of GAIS at Visit 4 is defined as the GAIS score assessed at Visit 4 in comparison to baseline.

Time frame: Group A: baseline and week 8; Group B: baseline and week 12

ArmMeasureValue (MEAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)2.8 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Physician Assessment of Global Aesthetic Improvement Score (GAIS), at Visit 4 (End-of-study Session)3.0 score on a scale
p-value: 0.3123Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Pigmentation Score at Visit 2

The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 2 = pigmentation score at Visit 2 - pigmentation score at baseline

Time frame: Group A: baseline and week 2; Group B: baseline and week 4

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Pigmentation Score at Visit 2-0.5 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Pigmentation Score at Visit 2-2.25 score on a scale
p-value: 0.6497Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Pigmentation Score at Visit 3

The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 3 = pigmentation score at Visit 3 - pigmentation score at baseline

Time frame: Group A: baseline and week 4; Group B: baseline and week 8

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Pigmentation Score at Visit 3-3 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Pigmentation Score at Visit 3-2.5 score on a scale
p-value: 0.8541Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)

The pigmentation score is a parameter measured by the Antera 3D system, calculated based on the variation (arbitrary units) and average level (arbitrary units). Variation (arbitrary units) indicates mean value within the region of interest of all deviations from the pigmentation average level in absolute value. Average level (arbitrary units) indicates the average concentration of pigmentation in the region of interest. To interpret the pigmentation score, skin pigmentation is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer pigmentation conditions. The overall pigmentation score ranges from 0 to infinity. Change from baseline in pigmentation score at Visit 4 = pigmentation score at Visit 4 - pigmentation score at baseline

Time frame: Group A: baseline and week 8; Group B: baseline and week 12

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)-9 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Pigmentation Score at Visit 4 (End-of-study Session)-7.5 score on a scale
p-value: 0.7326Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Pores' Index at Visit 2

The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 2 = pores' index at Visit 2 - pores' index at baseline

Time frame: Group A: baseline and week 2; Group B: baseline and week 4

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Pores' Index at Visit 20.126725 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Pores' Index at Visit 2-0.4088 score on a scale
p-value: 0.0006Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Pores' Index at Visit 3

The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 3 = pores' index at Visit 3 - pores' index at baseline

Time frame: Group A: baseline and week 4; Group B: baseline and week 8

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Pores' Index at Visit 30.299125 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Pores' Index at Visit 3-0.33025 score on a scale
p-value: 0.0758Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Pores' Index at Visit 4 (End-of-study Session)

The pores' index is an overall score representing skin porosity within the selected region of interest. It incorporates pore depth, size, and density-condensed into a single parameter. This index is particularly useful for the global evaluation of porosity reduction in before-and-after comparisons. Formula: Index = (V / S) × 1000 V = total volume of pores in the selected area (mm³) S = selected area (mm²) Change from baseline in pores' index at Visit 4 = pores' index at Visit 4-pores' indexe at baseline

Time frame: Group A: baseline and week 8; Group B: baseline and week 12

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Pores' Index at Visit 4 (End-of-study Session)-0.02675 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Pores' Index at Visit 4 (End-of-study Session)-0.63555 score on a scale
p-value: 0.0757Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Texture Score at Visit 2

The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 2 = texture score at Visit 2 - texture score at baseline

Time frame: Group A: baseline and week 2; Group B: baseline and week 4

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Texture Score at Visit 21.5 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Texture Score at Visit 2-4 score on a scale
p-value: 0.0088Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Texture Score at Visit 3

The texture score is a parameter measured by the Antera 3D system, calculated based on average roughness (Ra \[μm\]). Ra roughness, or average roughness, is a standard metric used to describe surface smoothness. It represents the average height of microscopic peaks and valleys on the skin surface. The Ra \[μm\] values range from 0 to infinity. To interpret the texture score, skin surface roughness is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate poorer skin texture. The overall texture score ranges from 0 to infinity. Change from baseline in texture score at Visit 3 = texture score at Visit 3 - texture score at baseline

Time frame: Group A: baseline and week 4; Group B: baseline and week 8

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Texture Score at Visit 32.75 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Texture Score at Visit 3-4.5 score on a scale
p-value: 0.0752Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Wrinkles' Score at Visit 2

The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 2 = wrinkles' score at Visit 2 - wrinkles' score at baseline

Time frame: Group A: baseline and week 2; Group B: baseline and week 4

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Wrinkles' Score at Visit 211 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Wrinkles' Score at Visit 2-23.5 score on a scale
p-value: 0.0002Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Wrinkles' Score at Visit 3

The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 3 = wrinkles' score at Visit 3 - wrinkles' score at baseline

Time frame: Group A: baseline and week 4; Group B: baseline and week 8

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Wrinkles' Score at Visit 320.25 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Wrinkles' Score at Visit 3-21.5 score on a scale
p-value: 0.066Wilcoxon (Mann-Whitney)
Secondary

Change From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)

The wrinkle score is a parameter measured by the Antera 3D system, calculated based on the indentation index (μm). The indentation index (μm) represents the average depth of all points or dents below the surface level. The indentation index (μm) values range from 0 to infinity. To interpret the wrinkle score, skin damage is categorized into five intervals: Mild: 0-25, Moderate: 25-50, Advanced: 50-75, Severe: 75-100, Very Severe: \>100. Higher scores indicate more severe wrinkle conditions. The overall wrinkle score ranges from 0 to infinity. Change from baseline in wrinkles' score at Visit 4 = wrinkles' score at Visit 4 - wrinkles' score at baseline

Time frame: Group A: baseline and week 8; Group B: baseline and week 12

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsChange From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)13 score on a scale
Arm B: 4-week Interval Between TreatmentsChange From Baseline in Wrinkles' Score at Visit 4 (End-of-study Session)-29.75 score on a scale
p-value: 0.0376Wilcoxon (Mann-Whitney)
Secondary

Visual Analogue Scale (VAS) During Treatment

The visual analogue scale (VAS) is a psychometric response scale that can be used in questionnaires, which a higher score suggests greater pain intensity. It ranges from 0 to 10 in increments of 1. A score of 0 cm indicates no pain and 10 indicates worst pain imaginable.

Time frame: Group A: week 0; Group B: week 0

ArmMeasureValue (MEDIAN)
Arm A: 2-week Interval Between TreatmentsVisual Analogue Scale (VAS) During Treatment5 score on a scale
Arm B: 4-week Interval Between TreatmentsVisual Analogue Scale (VAS) During Treatment6.5 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026